SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " harm " 2,196 found 🔀 AI-powered Shuffle
The States Try to Topple WarnerMount…Thus Begins the Local Antitrust Era
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Well, it looks like it’s time for another strategy column. Can I finally avoid writing about M&A? No, it seems I cannot. Admittedly, I’m a week early with this column, since I usually put it out every other week. But this news couldn’t wait. This will make three “Most Important Stories” in a row with a merger or acquisition as its centerpiece. First, Roku-Fox (an acquisition), then Comcast-NBCUniversal (a divestment!), and now the State AGs and the WGA’s lawsuits against Paramount’s pursuit of Warner Bros. Discovery (antitrust). M&A is usually the “most important” topic any given week, simply because a giant company merging or breaking up (or preventing those outcomes) can have the biggest impact on the streaming board. If you think about these companies as players in a game, changing the number of players is one of the biggest changes you can make. I shouldn’t really complain, either, since this lawsuit is very good news for customers and suppliers (econ speak for talent, workers and indie studios in Hollywood). So let me answer some questions about this potential trial, along with (shudder) making some heavily caveated predictions. I’ll also look at whether Hollywood must consolidate, whether or not the states can win, trouble at X-Box, Netflix’s YouTube binge, and more. Plus, I have five images that visualize this merger and the harm, including three brand new data looks you’ve never seen before. Subscribe Most Important Story of the Week - Can The States and the WGA Stop Hollywood’s Consolidation (Crisis)? If every other newsletter and news outlet is writing about the same story, I try to avoid writing about it as well, but I can’t ignore a story this consequential. The story of the last year was the fate of Warner Bros. Discovery, and this development potentially extends that saga into 2027. As I tried to figure out my angle, I realized, like my last column, I’m again faced with a series of questions. These questions, though, are much more forward-looking. Will the states win? Will the WGA win? If so, what happens to Warner Bros. Discovery? Either way, will this chill the market for future mergers? So you know what that means: predictions. About the future, no less, the hardest thing to predict.1 Just remember: nothing here comes with a guarantee. And the more confident someone is in their predictions, the less you should trust them. This situation is incredibly fluid, nuanced, uncertain and tenuous. So let’s try to explain what may happen. Question: Why File this Lawsuit? I’ll admit, a few months back, I was fairly pessimistic about the fate of this lawsuit. Rumors had started bubbling up that the state Attorneys General (in particular California) wanted to settle with either some minor divestments (usually CNN) or behavioral remedies. And that tracked for me: the states usually settle lawsuits, like the recent John Deere right-to-repair suit. Yet, they plan to fight this. (As they did the LiveNation-Ticketmaster monopolization trial and the Nexstar-Tegna merger.) Honestly, that also makes a ton of sense. Frankly, this move is just good politics for these State AGs. Most are still running for higher and higher office in blue states—some folks have emphasized that only Democratic AGs joined this suit, but given the Ellison/Trump ties, and fears of retribution, that tracks—and a high profile case like this will help them move up the electoral ladder, especially since Paramount and its leadership (the Ellisons, father and heir) have sided with the other side of the political aisle. That makes them unsympathetic to Democratic voters and Hollywood workers in particular. Why did this lawsuit happen? In addition to the very real concerns about industry consolidation, this is why. That said, I don’t think we would have seen this lawsuit for Netflix and Warner Bros., simply because they’re more sympathetic and aligned with Democrats. But those consolidation concerns are real. The “town”—meaning Hollywood and such—really is seeing the damage of mergers on this industry. That’s why the WGA also filed its own lawsuit in defense of workers as well. (Wildcard: What about Europe? Will they try to stop the deal, too? There have been some rumors out of the UK they may try to fight the deal, and UK enforcers just stopped a Getty Images-Shutterstock tie up, so there is precedence. This argument could go either way, though. On one hand, the EU doesn’t need to step in, cause they states are handling it. On the other hand, this could make the EU’s case easier. Just imagine if both sides coordinated. I’ll simply say, “We’ll see!”) Question: Will The State AGs or the WGA Win? Can the state AGs play David to Paramount-Skydance’s Goliath here? That’s really the whole thing, isn’t it? If you know this result, you could make a lot of money. When things are uncertain, it’s tempting to shrug and say, “Eh” meaning it’s a 50/50 proposition. I wouldn’t, though. When in doubt, you should expect that the merging parties succeed. AT&T did successfully buy Warner Bros., after all, and Disney bought Fox without any challenges. Many judges are extremely sympathetic to mergers, and I’d bet the state AGs get a judge who will allow the merger. (Even Obama-appointed judges often allow mergers.) As I understand it, we’ll see two main attacks. First, theatrical films. The AGs are arguing that, when it comes to share of box office and the number of both “wide releases” and blockbuster (or “tentpole”) films, the merging parties will have over 27% market share. Now, the Supreme Court once ruled from on high that any merger that exceeds 30% is presumptively illegal, but that’s guidance, not an ironclad bar. Still, the states will have to argue that this is close to having too much power, and with that power, this will likely further worsen the theater/studio splits in particular. Indeed, as Matthew Stoller pointed out, “just five studios are responsible for 95% of all blockbusters; if this merger goes through, then Paramount and Disney will control 60% of that.” So yes, movie studios will be very concentrated after this merger. Want me to visualize some of that? Well, here’s the share of films that grossed over $200 million at the domestic box office since 2022. (Note: this isn’t all films released in over 3,000 screens, but it is a good look at market power.) First, here are the 43 films by studio: Notice all the blue (Disney), orange (Universal), and purple (Warner Bros)? Yeah, those studios are powerful, and this combines Paramount with one of them. Here’s the look by studio and share of the films that grossed over $200 million: Now, if you look at that and also think, “Huh, should we break up Disney?” I’m with you. I’ve seen some folks poo-poo this idea that this is a real category, but it is! For an upcoming article, I’ve been pulling data on the share of top 100 films at the box office as a share of total box office, and it’s massive. Here’s the chart: (This analysis looks at The-Number’s top 100 films and total domestic box office each year.) To be clear, tentpoles make up 80.7% of the box office each year, so I do think it’s a genuine market. (To be clear, films grossing over $50 million make up 80% of the domestic box office, and films grossing over $100 million make up 64.1%.) I mean, the top 100 films at the box office make up 95% of each year’s grosses. Worse, the combined studios will likely cut output to flex that market power. Everyone can just look at what happened to Disney and Fox to see the precedent. (With fewer films, the remaining theaters have to give more for those few films that remain.) Here’s an image I’ve used a lot, the share of wide-release films from Disney and Fox over time: The AGs will also argue that this consolidation will also impact the cable industry. In this case, the consolidation is actually worse, but that environment is…complicated. Paramount will argue that the cable industry is shrinking. That said, predictions that cable will “go to zero” also don’t look very well supported by the data, as the declines are shrinking, meaning “cable” or “vMVPDs” will likely stabilize at some point. Can the state Attorneys General win on those two main arguments? I honestly don’t know. Again, I’d bet no, since history in general supports that, but it depends on the judge/jury and how they interpret the arguments. Notably, Paramount won’t face accusations about monopoly power in other areas, like streaming, news, sports rights, or vertical integration. I tend to disagree with leaving out sports rights, but I also see the appeal for a simpler case. The states also aren’t really pushing novel theories about labor harm either, which should help. (By the way, Sean McNulty at The Ankler wrote a great run through of potential options, and Capitol Forum also wrote a great paper on theatrical consolidation. Both these pieces predated the lawsuit. Matthew Stoller is also out with his analysis of the pros and cons of the case too.) In some ways, the WGA’s case is even stronger. Quoting Sean McNulty’s summary: “The WGA is citing WARNAMOUNT as crossing a 30% market share in multiple sectors, a number that the Supreme Court has precedent for deeming “presumptively anticompetitive” in a market. According to the WGA numbers, WARNAMOUNT would have represented: - 35% of film writing jobs between 2021 and 2024 - 36% of TV writing projects between 2022 and 2025 - 38% of overall deals between 2021 and 2024” Notably, antitrust enforcers did win recently in the Penguin-Simon & Schuster merger by focusing on labor impact, so don’t count this thinking out. (Wildcard: Will the states try to get a jury trial? Most likely no, they’ll let a judge handle it. If I’m them, though, I’d try to put this in front of a jury. Juries tend to understand monopoly power in a more realistic way than judges faced with legions of economists.) Question: What if They Win? What if They Lose?
Eli Lilly is reinventing the pharma business
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
Google's AI search features pose 'unacceptable risk' to children, new report finds
Common Sense Media found that across more than 2,600 test interactions, Google’s two built-in AI search functions routinely failed to recognize risky and harmful behavior.
‘Not harmless entertainment’: Montgomery County bill looks to tackle street takeovers
A new bill moving through the Montgomery County Council is aimed at tackling a big, sometimes dangerous problem on county streets.
New Alaska law will allow pharmacists to provide more healthcare
Lawmakers overrode a Gov. Dunleavy veto to pass a law that expands what pharmacists can do in the state. Experts say it will allow more Alaskans to access lifesaving care and medications for opioid use disorder.
Data Centers and Health: Understanding the Impacts and Taking Action
Join us for a webinar series that will equip attendees with the knowledge they need to speak confidently about the health and environmental justice harms from the rapid buildout of data centers.
Sale of multimillion-dollar T rex skeleton is big headache for scientists
Palaeontologists warn before auction at Sotheby’s in New York that super-rich collectors are harming research
iOS 26.6 Will Warn You About Malicious iMessages
Apple is adding a new warning about malicious iMessages in iOS 26.6, according to X user @limpless_skelly, who shared a mockup of the notification. The pop-up will warn users that a message could be trying to harm their iPhone or compromise their privacy. Apple asks users to share the message so it can guard against future attacks, and there are "Not Now," "Share With Apple," and "Don't Report" options to tap.
5-year update: Food Pharmacy at UF Health Jacksonville sees results
Improving the lives of patients one bite at a time. That’s the goal of a food pharmacy at UF Health.
Vistria sells stake in specialty pharmacy company to Warburg Pincus
Revenue at the Pittsburgh, Penn.-based Pantherx Rare had grown to nearly $10 billion from $2 billion since Vistria's investment.
Josh Grisetti dead: Broadway, ‘Marvelous Mrs. Maisel’ actor was 44
Josh Grisetti, the Broadway actor who charmed audiences with roles in "Something Rotten" and TV's "The Marvelous Mrs. Maisel," died by suicide. He was 44.
Scientists overwhelmingly against rule change that would give political appointees say over science grants
The window is quickly closing for members of the public to weigh in on proposed federal rule changes that, many scientists say, would politicize which studies get funded and profoundly harm American s...
Paramount Says States' Effort To Block WBD Deal "Will Only Harm Entertainment Workers"
Paramount hit back at an antitrust lawsuit filed Monday by attorneys general of 12 states seeking to block the company's pending $110 billion merger.
Aggie Venture Accelerator Welcomes Inaugural Cohort of Life Science Startups
The University of California, Davis Innovation and Economic Development Office has announced the inaugural cohort of the Aggie Venture Accelerator (AVA), selecting SinewUS, Pharm to Food and ThriveSpan Labs as the program’s first participating startups.
Anthropic's Claude Science could disrupt Kendall Square and biopharma
Few places on the planet have more at stake in AI’s transformation and disruption of life sciences than the Massachusetts biomedical ecosystem.
Germany pushes through healthcare reform package despite pharma's drug discount resistance
Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own government, German lawmakers late Friday voted to pass health insurance ref | Even as the effort has met with fierce pushback, German lawmakers late Friday voted to pass health insurance reforms aiming to cut healthcare costs, in part by hiking up mandatory rebates that pharmas must pay on branded medicines.
"I was verbally blasted by Pierre." Xbox and Halo Studios' Pierre Hintze has reportedly 'repeatedly' been referred to HR. Is he the right person to lead Halo?
Xbox has a new CEO, Asha Sharma, and one of her stated goals is to boost the Halo franchise. Is Pierre Hintze the right person for the job?
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
/PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has completed the acquisition of...
Pesticide makers stack wins against US environmental, public health groups
The U.S. Supreme Court handed a major legal victory to German agrichemical and pharmaceutical company Bayer last month when it reined in thousands of lawsuits accusing the German company of failing to warn users that glyphosate, the active ingredient in its Roundup weedkiller, causes cancer.
Who’s more to blame for frustration at the pharmacy—insurers changing formularies or prescribers failing to keep up?
Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.
Ohio's Charming Cincinnati Suburb Is A Vibrant City Bursting With Unique Foodie Finds And Entertainment
This unassuming city just beyond Cincinnati's borders is home to a "theme park of food," as well as top-notch restaurants and buzz-worthy events.
Who’s more to blame for dashed ‘scrip’ fills—insurers restricting drug coverage or prescribers failing to keep up?
Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.
Health insurance giants are fighting efforts to break them up
UnitedHealth Group, CVS Health and Cigna are suing states over new laws targeting their pharmacy businesses.
Your smartwatch might be making your sleep worse
For people with insomnia or a fixation on perfect sleep, experts say wearable data can sometimes do more harm than good.
Your smartwatch might be making your sleep worse
For people with insomnia or a fixation on perfect sleep, experts say wearable data can sometimes do more harm than good.
Big Medicine threatens your wallet and your health. But there is a solution.
The Break Up Big Medicine Act has bipartisan support, and builds on new laws restricting pharmacy benefit managers.
After years of teasing, the viral Nopia synth is ‘basically finished’
The “harmony machine” will be out by the end of the year for “around £550.“
Microsoft defends Asha Sharma, says she is an American CEO and Xbox layoff had nothing to do with H-1B
As Asha Sharm, the CEO of Xbox, came under vicious trolling after the gaming division of Microsoft announced the elimination of 3,200 positions, Microsoft came to her rescue and clarified that it had nothing to do with replacing Americans with foreign workers. Frank X Shaw, the lead for the communications for Microsoft, also addressed the 'Indian-origin' angle of the immigration debate and called Asha an American born, educated CEO from Wisconsin.
I moved from Connecticut to the South and didn't like it, so I moved back
Connecticut native Sandra Bonola moved to South Carolina for Southern charm and a cheaper lifestyle. Instead, she found it hot, crowded, and pricier than expected.
Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut health.
How Maison de Sabré built a cult business of bag charms from scraps
The Sabré brothers turned their cutting-room floor scraps into covetable bag charms. They believe the whimsy—and sustainability—they’re offering is key to being a next-generation luxury brand.
What’s really going on with mental health?
Changing terminology risks misleading policymakers and harming those in most need
Unionized Bethesda Workers Plan Strike Over Xbox Mass Layoffs
Following the recent confirmation that layoffs related to Asha Sharma's Xbox reset have resulted in significant layoffs at ZeniMax-run studios—amounting to 50% of Id Software's workers and 25% of Bethesda's—OneBGS, the CWA-affiliated Bethesda Game Studios Union, has announced that its workers has...
How climate change harms human health — and what can be done
From air pollution to wildfires, from heat waves to vector-borne diseases, climate change harms our health and causes significant stress to the healthcare system. Horizons moderator William Brangham explores what can be done to protect people from a warming world with Victor Tsao of the U.S. National Academy of Medicine and Lisa Patel of the Medical Society Consortium on Climate and Health.
NC’s State Health Plan switching who administers its members’ benefits, again
The State Health Plan announced who won its health and pharmacy benefits contracts.
Asha Sharma, the outsider handed the Xbox controls
Elevated to fix Microsoft’s struggling gaming division, she is making tough decisions about its future
Harmful blue-green algae toxins detected in Lake Jesup
Harmful blue-green algae toxins detected in Lake Jesup, Florida. Avoid contact with water and keep pets away. Health alert issued.
Apollo inks €3B equity deal for stake in Bayer's contraceptives business
Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal
Germany's lower house of parliament passes healthcare reform
Germany's lower house of parliament on Friday approved a bill to overhaul the creaking health insurance system that has drawn fierce opposition from drugs companies which fear tougher pricing measures will harm profitability and reduce investment.
Bayer sells stake in contraceptives business to Apollo in €3bn financing deal
Sale will help German pharmaceuticals group to bolster its balance sheet after years of litigation over Roundup weedkiller
Applications for new Doctor of Medical Science program now open
Campbell University College of Pharmacy & Health Sciences is now accepting applications for its new Doctor of Medical Science (DMSc)… More on this post
Fed appoints task forces led by Marc Andreessen, Asha Sharma
Economists, researchers, and industry insiders like Marc Andreessen and Asha Sharma have joined Fed task forces to revamp economic policies.
Online Sports Bettors 15 Times More Likely To Miss Bill Payments Than In-Person Gamblers, Report Says
Online sports bettors report more financial harm than those who only gamble in person.
The 1 Trendy Health Product a Colon Surgeon Would Never Buy
In TODAY.com’s Never Have I Ever series, a colorectal surgeon explains why this product is probably doing your intestines more harm than good.
Impressive growth of Eli Lilly's obesity business is coming from all over the world
Eli Lilly's international GLP-1 business is booming, giving investors another reason to stick with the stock.
Former Sen. Jack Latvala, once considered one of the most powerful men in Florida Politics, has died
Latvala was known as much for his kindness and southern charm as he was for his political finesse.
HEALTH FIRST: Managing cardiac sarcoidosis and heart disease
Megan Clark, a clinical pharmacist practitioner with Novant Health’s Heart and Vascular Institute, was in the studio to discuss the disease and treatment options.
Bonnie Tyler, who topped the charts with epic 'Total Eclipse of the Heart,' has died at 75
Bonnie Tyler, the gravelly voiced, Grammy-nominated Welsh pop star best known for singing the chart-topping power ballad “Total Eclipse of the Heart” in 1983 and seeing new generations succumb to its bombastic charms during solar and lunar eclipses, has died. She was 75.
Health Insurance Giants Are Fighting Efforts to Break Them Up
UnitedHealth Group, CVS Health and Cigna are suing states over new laws targeting their pharmacy businesses.
Hungary moves to overhaul university models banned from Horizon Europe
Hungary’s new government is aiming to overhaul the governance model of the institutions and universities that lost access to Horizon Europe and Erasmus+ funds “in a short timeframe,” according to Péter Horváth, the new state secretary for science policy and innovation. “As of today, the two non-university foundation-controlled institutions under my remit have been transformed,” he told Science|Business. “We hope the universities will follow and that this will be enough to satisfy the EU’s demands.”Under the previous government, led by Viktor Orbán and his Fidesz party, many academic and scientific institutions were restructured and made into special public trust foundations, with members strongly linked to the government given lifelong mandates and significant decision-making powers with little oversight. The European Commission deemed that this undermined academic freedom and transparency in the country, leading to a ban on 34 institutions in 2022, including 21 universities, which saw academics in Hungary lose access to Horizon Europe grants. The new Hungarian government, elected in May and led by Péter Magyar and his Tisza Party, has promised to dismantle this governance model and restore the institutions to EU programmes. As a result, the European Commission has promised to return access to the Erasmus+ education mobility programme, but so far no concrete agreement has been made on the Horizon Europe programme for research and innovation. Hungary has already made legislative changes in June to allow the institutions to be reformed and set a timeline for the implementation.The non-university foundations, which are mainly cultural centres such as the Foundation for Hungarian Culture or the Makovecz Campus Foundation, will all be dissolved by August 31 this year, a date tied to EU-set milestones that Hungary must meet to unlock frozen funds, with control transferred to relevant ministries. Meanwhile, the universities will have until 31 August 2027. For each university foundation, the government will set the dissolution date and the body to take over operations. There is no final decision on a permanent new model for the universities, according to Hungarian MEP Eszter Lakos, who is shadow rapporteur for the Horizon Europe specific programme, a separate piece of legislation detailing implementation rules for the EU’s next research programme, due to start in 2028. “The aim of the transition year is to settle this with [the universities], not to impose a model, and not to put them under state control,” she told Science|Business. “The goal is to give academic independence back to universities.”There are three models that are most likely to be implemented. One would be a return to a traditional, state-run model. Another could be a newer, more self-standing public institution. A third option would be a reformed version of the foundation models that meet EU standards. According to Lakos, the dismantling of the system put in place by the Orbán government is well underway and if all goes according to plan, Hungary could regain access to EU research money by the start of the next academic year in 2027. “I believe that the Hungarian government is doing the necessary changes so the universities could return as beneficiaries to Horizon from the next school year,” she said. In the meantime, “the universities, institutes and cultural assets carry on under proper public stewardship rather than a handful of unaccountable trustees,” said Lakos. The laws passed in June impose new safeguards: board terms are capped at four years and renewable only once, appointments are made through open competitions and sitting politicians cannot join joining these boards.It remains unclear whether a domestic science funding programme set up as a back-up scheme by the former government following the EU funding ban, called HU-rizon, could be continued. “This programme should never have had to have been established in the first place, but it has proven to be quite popular,” he said. “I am considering continuing this programme with a refined focus on helping international collaborations.”Re-organising the research network One of the first priorities for Horváth and his cabinet is to resolve questions over the future of the Hungarian Research Network, Hun-Ren. The network of academic institutes was taken away from the Hungarian Academy of Sciences in 2019 and turned into a quasi-private organisation, with similarities in its governance to the public trust foundations.Horváth and his team have consulted over 5,000 representatives from the network and the conclusion is broad unhappiness with the directors of all the institutes involved. “We have presented the results to the president and the chief executive of the network and this is currently being discussed,” Horváth said. The plan is to re-integrate the network back into the Academy of Sciences but in an improved way, “learning from mistakes of the past,” he added. The government also wants to reintegrate four humanities and social science research centres into the network that the previous government had transferred to Eötvös Loránd University. The transfer brought sharp criticism from the academic community, with a group of Hungarian research heads, including European Research Council grant recipients, sending an open letter to Orbán warning that the transfer would “cause historically significant harm to the entirety of Hungarian scientific life.” The transfer was “one of the biggest shames in Hungarian research in the past 20 years,” Horváth said. “We want to immediately re-integrate them back into the research network and to regain the trust of these institutions, because the way they were treated was really unfair.”Another pressing issue is the Élvonal Excellence Research and Talent Development Foundation, led by Nobel laureate Ferenc Krausz. The foundation signed a financing agreement with the former government earlier this year for a budget of over €730 million over the next five years. The goal is to create a world-class centre to attract top talent from abroad and to develop local researchers. But there was little transparency about this foundation, and news of its huge budget, which is nearly as much as Hungary’s entire research budget, caused a stir in the media following the recent elections. Another issue is that, as with the foundation boards of the institutes banned from Horizon Europe, there was little-to-no oversight of decisions led by Krausz. “It was an excellent idea but an unacceptable execution,” Horváth said of the foundation. “The fact that this is out of the Hungarian funding scheme, mostly concentrating on one person who decides on the budget is unacceptable for us.”The government plans to merge the centre with the National Research, Development and Innovation Office, the country’s R&D funding agency, with a reduced budget. Horváth is hopeful that Krausz will still be involved. The new government’s R&D goalsA phrase that crops up regularly during the discussion with Horváth is “democratic process.” The new state secretary is determined to involve Hungary’s research community in shaping future policies. This marks a departure from the previous government’s approach, and several people in Hungary’s research community have commented on the openness of the new government. In terms of concrete goals, Horváth and his team already have plans. He wants to create a new science fund in Hungary, based on the best practices of other European countries. The fund would not be tied to annual government budgets and would provide long-term, stable financing. “If we were to succeed in creating this fund, then I think it would be one of the biggest achievements for me in this period of government,” Horváth said. On the innovation side, he is looking into how best to bring in the private sector. “We want to make sure that we are working with the private sector to support innovation,” Horváth said. One of his big aims is to introduce entrepreneurship teaching into high schools. Hungary already has a reputable national academy offering research and innovation training in the field of natural sciences, and Horváth wants to expand this to all disciplines and across the whole country. “One of the main ways to elevate our innovative businesses is to teach our children to be innovative,” he said. “This will probably need ten years to pay off, but this is what we should do. Our aim is to make Hungary strong in our region, and this is what is needed.” Related articlesHungary’s Horizon Europe performance in numbersCommission unlocks Erasmus+ cash for Hungary, Horizon could be next‘Academic Huxit.’ Hungarian researchers speak out on impact of EU ban A more difficult task will be funding. The new government is aiming to increase research spending to 2% of the GDP by 2030, and then increase it to 3% in line with EU objectives. Currently, spending sits around 1.3%. But according to Horváth, the current budget, inherited from the previous government, is “heavily in the negative,” so any plans to increase research spending will have to start next year. Achieving 2% by 2030 already needs a big push, almost doubling the research budget. “This is something we’d definitely like to reach, and something I can see us achieving,” he said. “From the 2030s, I’d like to see an innovative generation growing up that can help us reach the 3% target.” Positivity in the new governmentDespite the many challenges facing Horváth and his team, the mood is positive. “It feels a bit like a start-up right now. Everyone is working 24/7, day and night, trying to do as much as they can. There is a lot of energy,” he said. It is a big change for the state secretary who, like many in his cabinet, is coming from a background in research or business, and not in politics. “Six weeks ago, I was sitting with my microscope and my research PhDs, so it’s been a big change for me,” said the computer scientist, who was previously the director of the Institute of Biochemistry at the Hun-Ren Biological Research Centre in Hungary and worked at the Institute for AI for Health at Helmholtz Munich. But he is relishing the task to transform the country’s R&D landscape. “We feel enormous support from the Hungarian people, but also from Europe,” he said. “We’ve received a lot of letters of support from around Europe. There is big trust there, and huge responsibility on our side. We want to get everything back on track, and there’s a lot to do.”
Health risk fears for storks in Europe over ‘junk food’ from landfill
Rubbish dumps can expose birds to contaminants, raising questions over whether landfill foraging helps or harms
Oregon eyes $421 million in Medicaid cuts, including fewer benefits and limits on prescription drugs
Major cuts are coming to the Oregon Health Plan, the state’s free healthcare program covering 1.4 million children and low-income adults. But the group of experts Gov. Tina Kotek charged with minimizing the harm of those cuts has given her no definitive recommendations.
California dad who drove family off cliff has charges dropped after mental health treatment
A judge dismissed the charges Monday after Dharmesh Patel completed a two-year mental health diversion program with a Stanford University psychiatrist and a family therapist.
Report: Microsoft will make even more of its games exclusive to Xbox — as multiplatform strategy totally fails. What's going on?
Xbox's loathed "Project Latitude" strategy which saw Microsoft support its biggest rival with content is ending, with CEO Asha Sharma doubling down on exclusives.
Nearly 3 in 4 scam victims say it harmed mental health, report finds
Americans lost an estimated $68 billion to scams in 2025, while many victims reported lasting emotional and financial impacts, according to Gallup and the Stop Scams Alliance.
Danielle DiBari, Senior Vice President of Business Operations, Chief Pharmacy Officer and Chief Procurement Officer named to Becker's 2026 "101 Hospital and Health system Chief Pharmacy Officers to Know" List
NYC Health + Hospitals announced that Danielle DiBari, Senior Vice President of Business Operations, Chief Pharmacy Officer and Chief Procurement Officer,
Mitch McConnell and the complications of speculating about someone's health
It's natural to wonder about a public figure's health – especially a politician who influences Americans' lives – but speculation can be harmful, too.
Research shows how behavioral science silently protects American consumers and patients
A new Proceedings of the National Academy of Sciences (PNAS) special feature highlights the critical role of behavioral and decision sciences in U.S. governance. The publications demonstrate how psychological ...
Billionaire John Arnold commits $2.6 million to study online sports betting risk
John Arnold, who runs Arnold Ventures with his wife, Laura, is investing $2.6 million for university research into potential harms of online sports betting.
Four states seeking $1.4 trillion in penalties in child social media addiction trial, Meta says
Four states are seeking $1.4 trillion from Meta over claims Facebook and Instagram were designed to be addictive to children without any warnings on the alleged harms of the apps.
A blue city shakes off politics over US forward Balogun's red card controversy
A city known for angry protests, grunge and wearing head-to-toe black was transformed into a harmonious sea of red, white and blue on Monday.
Air pollution may be changing sperm
Harmful nitrogen dioxide and ozone levels could affect fertility and pregnancies.
Microsoft cuts 4,800 jobs as Xbox studios spin off in gaming reset
The Xbox restructuring will involve divestment of four studios, Xbox's new head, Asha Sharma, said in a note to employees.
Vertex to buy Crinetics in $10 billion deal
Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of about $10 billion, the companies said on Monday.
Primus Mbawuike, M.D., Pharm.D., Joins UAMS Health Family Medical Center in Pine Bluff
Primus Mbawuike, M.D., Pharm.D., has joined the University of Arkansas for Medical Sciences (UAMS) Family Medical Center in Pine Bluff where he will offer comprehensive care for all ages with additional expertise in pharmacy.
Xbox CEO Asha Sharma wants the company to "entertain more than a billion people" every day: here's why that's a deeply unrealistic thing to say
The company will have to do so with four less studios under its belt.
Why Business Should Oppose OMB’s Plan To Politicize Grantmaking
The Office of Management and Budget is proposing sweeping changes to federal grantmaking that could harm American science, economic competitiveness and national security
AeroSafe Global turns sustainable healthcare logistics into a high-growth business
Rochester-based AeroSafe Global pioneers cold-chain-as-a-service, employing nearly 200 locally and operating in 80 countries with sustainable pharma logistics.
Examining Algal Blooms in Blue Mesa
Using satellite data, researchers connected harmful algal blooms with warm water and low water levels at one of Colorado's largest reservoirs.
Millions may be getting the wrong cholesterol test
A new study suggests that apoB, a blood test that measures harmful cholesterol particles, is better than standard LDL cholesterol testing for deciding who needs more intensive treatment. Researchers found it could prevent more heart attacks and strokes while remaining cost-effective for the U.S. healthcare system.
Keri Hilson breaks down her viral “music can harm” tweet and weighs in on the state of the industry
Keri Hilson music can harm tweet: The “Pretty Girl Rock” singer addressed her cryptic post on X at the 2026
Former CDC chief medical officer says RFK Jr. caused ‘irreparable harm’
Dr. Debra Houry, the former chief medical officer at the Centers for Disease Control and Prevention (CDC), decried the direction of the agency under Department of Health and Human Services (HHS) Se…
Phillies on the Pharm: 7/5/2026
Painter with another solid start for the IronPigs
‘All kinds of weird’: novelty store to open in midtown Sacramento
Ginger & Raven will operate on 1731 L St. selling novelty and accessory items such as keychains, compacts and Italian charm bracelets.
Doctors Say Staying Sedentary Can Harm Your Health in These 5 Ways
Doctors explain what happens when you don’t walk regularly, from heart health decline to muscle loss, bone density changes, and cognitive effects.
Majority of UK smokers wrongly believe vaping is as harmful as cigarettes, experts find
Analysis shows public understanding about vaping, which is far less harmful than smoking, has plummeted in past decade
CVS Health Corporation (CVS) Shares Up Significantly After Jim Cramer Said He Was Looking For A Good Year
We recently published Jim Cramer’s Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026. CVS Health Corporation (NYSE:CVS) is one of the stocks discussed by Jim Cramer. Pharmaceutical retailer CVS Health Corporation (NYSE:CVS) has become one of Cramer’s top stocks in the sector. Throughout this year, the CNBC TV […]
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
Compare sector breadth, yield, and recent performance as these two healthcare ETFs take different approaches to growth and income.
The evidence against “ultra-processed” foods is weaker than you think
New analysis suggests other factors may explain the harms blamed on “ultra-processing”
Travis Kelce marries Taylor Swift in a tux by Christian Dior
Taylor Swift may have brought the glamor to her lavish wedding weekend, but Travis Kelce brought the charm.
Harsh Medicine: Fixing Science’s Gender Gap
Women now enter medicine in numbers equal to men, yet they remain largely underrepresented. That’s harmful to science and patient care.
Jordan Spieth Warns Sports Betting Could Harm Golf Fan Behavior at Tournaments
Jordan Spieth believes the growth of sports betting is changing fan behavior at golf tournaments and says the issue may soon need to be addressed.
Xtalks Announces its Life Science Webinar Calendar for July 2026
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
Greenville pharmacy acquires Ballston Spa business
Kelly’s Pharmacy in Greenville has expanded into Saratoga County. According to an announcement made Wednesday, the pharmacy has acquired O’Brien Pharmacy in Ballston Spa.
How does Maryland stack up in preventing and prosecuting Medicaid fraud?
High-profile federal Medicaid fraud prosecutions, including the indictment of a Dundalk pharmacist, raised questions about how Maryland works to prevent and prosecute fraud.
Why you should wash new clothes before wearing; signs that you are aging well; effective leadership in health care; plus other stories with Vanderbilt Health sources
Jami Miller, MD, Professor of Clinical Dermatology, and David Gaston, MD, PhD, Assistant Professor of Pathology, Microbiology and Immunology, are quoted in a Southern Living piece about the importance of washing new clothes before wearing them. Dyes, chemicals, mold and bacteria are all potential troublemakers lurking around your new duds. Parul Goyal, MBBS, Associate Professor of Clinical Medicine, was quoted in a Huff Post story outlining signs that you are aging well. Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, was interviewed by Healio for a story headlined, “Effective leadership in health care ‘starts with listening.’” AAMC News reporter Patrick Boyle interviewed Wes Ely, MD, Professor of Medicine and Critical Care, for a story about ICU delirium. PharmaVoice reporter Kelly Bilodeau interviewed Romney Humphries, PhD, Vice Chair and Executive Medical Director, Clinical Services, for a story about the CDC’s new data that shows an alarming increase in the prevalence of a gene that can make “nightmare bacteria” significantly harder to treat. American Community Media interviewed William Schaffner, MD, Professor of Preventive Medicine, for a piece about Ebola that was reused by several media outlets around the U.S., including The Mississippi Link. Stacie Dusetzina, PhD, Professor of Health Policy, was quoted by The Independent in a story about how Medicare will soon cover weight-loss drugs. Courtney Schadt, MD, Associate Professor of Dermatology, was interviewed by Tennessean reporter Beth Warren, about tanning safety and tanning fads circulating social media. WKRN News 2 interviewed Amanda Peltier, MD, Professor of Neurology, about the correlation between head trauma and ALS following the diagnosis of former Titans running back Chris Johnson.
The future of Oxford: Science, technology, and collaboration
In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.
I left New York for small town 5 years ago; I wish I could move back
We left New York City for a charming village about an hour away. After just a few years, we started missing the city and planning to move back.
Croatia criticised for ‘unambitious’ changes to 2022 science law
Croatia’s science ministry has been accused of a lack of ambition, and even incompetence, over proposed changes to the country’s 2022 science law. Critics say an opportunity has been missed to fix wider shortcomings in the research and universities system.“This law, like all the previous ones, will not significantly change the current state of science in Croatia,” Vlatko Silobrčić, a member of the Croatian Academy of Sciences, told Science Business. “A small shift here and there will not have a significant impact.”The 2022 law introduced multi-year block grant financing of research, based on results, and changes intended to boost employment and career progression for researchers and lecturers. But implementation of the law has been uneven. “It became apparent that certain of its provisions were subject to different interpretations by higher education institutions and scientific institutes,” the science ministry said in its proposal for change. “This caused legal uncertainty in the system, administrative difficulties in implementation and, in certain cases, unequal treatment of teachers, scientists and students.”Most of the proposed amendments deal with technicalities in hiring and promoting staff, such as extending the committee deadlines from 60 to 90 days, or allowing applicants to cite all of their achievements and not only those since their last appointment.Both the ministry and Croatian media highlighted changes that would raise the retirement age from 65 to 67 years and allow part-time students 15 year rather than 10 years to finish their studies.The change to retirement age has been criticised for reinforcing a weakness in the system. According to Matko Marušić, professor emeritus at the University of Split, this will “allow unproductive teachers to advance and work longer, while hindering and discouraging productive ones.”A longtime campaigner for excellence-based meritocracy, he sees little hope in the new legislation. “I am not optimistic that things will improve,” he told Science Business. “As recent changes to the law in Croatia show, the legal framework is becoming increasingly hypocritical and harmful.”For Marušić, who analyses Croatia's university system in a recently published book, the situation is “unfavourable and constantly deteriorating” due to the criteria used for academic advancement.“The key criterion for advancement should be scientific productivity,” he said. “In Croatia [. . .] scientific criteria are increasingly lowered, and ineffective and absurd criteria such as waiting times for promotion and age limits for remaining in a job are promoted.” He would also like to see better criteria for the quality of teaching at universities. “In practice, teaching is not monitored or evaluated,” he said, estimating that up to a third of teaching simply does not take place. “Under the guise of university autonomy and bad laws, universities and faculties are allowed to earn additional money by increasing enrolment quotas that have nothing to do with the needs of the labour market.” Lack of ambitionDora Kršul, a reporter at Telegram.hr who covers science policy in Croatia, finds the rationale for changes “bizarre.” “The ministry responsible for supervising the uniform application of the law is changing the law because it is being implemented unevenly,” she said. “This primarily speaks to the power relationship in the sphere of science and higher education in Croatia, that is, the question arises as to who actually manages this system.”Rather than raising quality, she continued, the changes appear to be designed to help vocational and applied universities who have not been complying with the law.The Independent Union of Research and Higher Education Employees of Croatia said that the changes were “unambitious” and represent a missed opportunity for more important changes. “We think some of the changes are even negative,” it said in its statement on June 25. One of these is introduction of an “assistant” job title that allows people to be hired only for the duration of a project. Related articles: Elections to top science bodies test Croatia’s gender equality in researchSlovakia revises R&D approach to increase focus on competitivenessLatvia pilots citizen engagement in research grant evaluationsThe union’s president, Tvrtko Smital, who was part of the 15-member working group tasked with drafting the changes, told the local media there was a “worrying lack of ambition” in the process, and “lack of competence” in terms of research experience and understanding the problems in the system.“There is no clear will to deal with the problems,” said Smital, an assistant professor of marine and environmental sciences at the Ruđer Bošković Institute in Zagreb. “It’s a combination of unambitiousness and incompetence,” he went on, expressing his “deep frustration” with the situation. “There is no strategy, no clear thinking, and money is not being spent optimally.”Croatia’s science ministry has not responded to requests for comment.
Southern California’s total tobacco bans aren’t helping public health
Instead of pursuing tobacco bans, state health officials should prioritize proven harm reduction policies.
Starmer to issue formal apology to mothers and children harmed by historic forced adoption policies
Between 1949 and 1976, an estimated 185,000 babies were taken from unmarried mothers and placed for adoption in England and Wales
UToledo Health Pharmacy Residency Program Awarded Competitive National Grant
A $25,000 ASHP Foundation grant will grow UToledo's PGY1 Pharmacy Residency Program to seven residents, helping meet growing demand for pharmacist-led patient care.
Summer travel health: tips for heat exhaustion, insect bites and travel vaccines
Stay healthy while traveling with help from CVS Pharmacy and MinuteClinic. Get vaccines, refill prescriptions and prepare for summer travel risks.
PwC predicts: Providers, payers, pharma, medtech—all will have new to-do lists after the midterm elections. And that’s regardless of results.
With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in?
Trinity Health Grand Rapids works to offer more free medication
Trinity Health Grand Rapids is rolling out a new program that aims to get prescription medicine to some of the lowest-income patients in West Michigan.
UN panel warns AI is outpacing scientific understanding, government policy
AI is already being used to generate misinformation and other harmful content and could be exploited for fraud, cyberattacks and biological threats.
'NCIS' shocker as Michael Weatherly returns as beloved Tony DiNozzo
What a week for "NCIS" universe. First, fans of the CBS mega-franchise were hit with the big news that Mark Harmon is bringing his iconic Gibbs character to every "NCIS:
Nearly three in four US scam victims report mental health harm, poll finds
Gallup survey says the financial toll of scams in the United States in 2025 was estimated at $68bn.
Anthropic debuts AI-driven pharma R&D tool, Claude Science
Anthropic launches Claude Science as big tech companies increasingly eye expansion in the wider healthcare and life sciences space.
Anthropic launches Claude Science for pharma researchers
Anthropic had made a big life sciences play with the launch of Claude Science, an AI 'workbench' for researchers involved in drug discovery.